Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma.

Ferro DP, Falconi MA, Adam RL, Ortega MM, Lima CP, de Souza CA, Lorand-Metze I, Metze K.

PLoS One. 2011;6(6):e20706. doi: 10.1371/journal.pone.0020706. Epub 2011 Jun 16.

2.

The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia.

Adam RL, Silva RC, Pereira FG, Leite NJ, Lorand-Metze I, Metze K.

Cell Oncol. 2006;28(1-2):55-9.

3.

Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.

Bedin V, Adam RL, de Sá BC, Landman G, Metze K.

BMC Cancer. 2010 Jun 5;10:260. doi: 10.1186/1471-2407-10-260.

4.

Fractal dimension of chromatin: potential molecular diagnostic applications for cancer prognosis.

Metze K.

Expert Rev Mol Diagn. 2013 Sep;13(7):719-35. doi: 10.1586/14737159.2013.828889. Review.

5.
6.

Molecular characteristics and chromatin texture features in acute promyelocytic leukemia.

De Mello MR, Albuquerque DM, Pereira-Cunha FG, Albanez KB, Pagnano KB, Costa FF, Metze K, Lorand-Metze I.

Diagn Pathol. 2012 Jun 28;7:75. doi: 10.1186/1746-1596-7-75.

7.

Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.

Dutoit JC, Vanderkerken MA, Verstraete KL.

Eur J Radiol. 2013 Sep;82(9):1444-52. doi: 10.1016/j.ejrad.2013.04.012. Epub 2013 May 28.

PMID:
23726124
8.

[Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].

Deng SH, Xu Y, Mai YJ, Wang YF, Zhao YZ, Zou DH, Qiu LG.

Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):217-21. Chinese.

PMID:
18843972
9.

Nuclear fractal dimension as a prognostic factor in oral squamous cell carcinoma.

Goutzanis L, Papadogeorgakis N, Pavlopoulos PM, Katti K, Petsinis V, Plochoras I, Pantelidaki C, Kavantzas N, Patsouris E, Alexandridis C.

Oral Oncol. 2008 Apr;44(4):345-53. Epub 2007 Aug 9.

PMID:
17692559
10.

[Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].

Conté L G, Figueroa M G, Lois V V, Cabrera C ME, León R A, García L H, Rojas R H.

Rev Med Chil. 2008 Jan;136(1):7-12. doi: /S0034-98872008000100001. Epub 2008 Apr 30. Spanish.

11.

Nuclear fractal dimension in oral squamous cell carcinoma: a novel method for the evaluation of grading, staging, and survival.

Mincione G, Di Nicola M, Di Marcantonio MC, Muraro R, Piattelli A, Rubini C, Penitente E, Piccirilli M, Aprile G, Perrotti V, Artese L.

J Oral Pathol Med. 2015 Oct;44(9):680-4. doi: 10.1111/jop.12280. Epub 2014 Nov 4.

PMID:
25367085
13.
14.

Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.

Jakob C, Sterz J, Liebisch P, Mieth M, Rademacher J, Goerke A, Heider U, Fleissner C, Kaiser M, von Metzler I, Müller C, Sezer O.

Leukemia. 2008 Sep;22(9):1767-72. doi: 10.1038/leu.2008.159. Epub 2008 Jun 26. Erratum in: Leukemia. 2008 Sep;22(9):1812.

PMID:
18580957
15.

[Long-term survival and prognostic factors in multiple myeloma treated with conventional chemotherapy. Report of 109 cases].

Ben Abid H, Meddeb B, Ben Abdallah M, Bel Hadj Ali Z, Hafsia R, Ben Lakhal R, Gouider E, Aissaoui L, Landoulsi I, ben Abdeladhim A, Hafsia A.

Tunis Med. 2000 Dec;78(12):705-12. French.

PMID:
11155374
16.

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.

Terpos E, Katodritou E, Tsiftsakis E, Kastritis E, Christoulas D, Pouli A, Michalis E, Verrou E, Anargyrou K, Tsionos K, Dimopoulos MA, Zervas K; Greek Myeloma Study Group.

Haematologica. 2009 Mar;94(3):372-9. doi: 10.3324/haematol.2008.000638.

17.

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation.

Neben K, Jauch A, Bertsch U, Heiss C, Hielscher T, Seckinger A, Mors T, Müller NZ, Hillengass J, Raab MS, Ho AD, Hose D, Goldschmidt H.

Haematologica. 2010 Jul;95(7):1150-7. doi: 10.3324/haematol.2009.016436. Epub 2010 Mar 10.

18.

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.

Avet-Loiseau H, Durie BG, Cavo M, Attal M, Gutierrez N, Haessler J, Goldschmidt H, Hajek R, Lee JH, Sezer O, Barlogie B, Crowley J, Fonseca R, Testoni N, Ross F, Rajkumar SV, Sonneveld P, Lahuerta J, Moreau P, Morgan G; International Myeloma Working Group.

Leukemia. 2013 Mar;27(3):711-7. doi: 10.1038/leu.2012.282. Epub 2012 Oct 3.

19.

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.

Granell M, Calvo X, Garcia-Guiñón A, Escoda L, Abella E, Martínez CM, Teixidó M, Gimenez MT, Senín A, Sanz P, Campoy D, Vicent A, Arenillas L, Rosiñol L, Sierra J, Bladé J, de Larrea CF; GEMMAC (Grup per l’estudi del mieloma i l’amiloïdosi de Catalunya).

Haematologica. 2017 Jun;102(6):1099-1104. doi: 10.3324/haematol.2016.158303. Epub 2017 Mar 2.

20.

[Clinical analysis of newly diagnosed multiple myeloma patients with renal dysfunction].

Zhu W, Lu J, Lu J, Hou J, Huang X, Chen W.

Zhonghua Yi Xue Za Zhi. 2015 Mar 17;95(10):741-4. Chinese.

PMID:
26080844

Supplemental Content

Support Center